Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Department of Pharmacy and Health System Sciences, Northeastern University, Boston, MA, USA.
J Gen Intern Med. 2022 Nov;37(15):3893-3899. doi: 10.1007/s11606-022-07410-x. Epub 2022 Jan 31.
In older patients with atrial fibrillation (AF), physical, cognitive, and psychosocial limitations are prevalent. The prognostic value of these conditions for major bleeding is unclear.
To determine whether geriatric conditions are prospectively associated with major bleeding in older patients with AF on anticoagulation.
Multicenter cohort study with 2-year follow-up from 2016 to 2020 in Massachusetts and Georgia from cardiology, electrophysiology, and primary care clinics.
Diagnosed with AF, age 65 years or older, CHADS-VASc score of 2 or higher, and taking oral anticoagulant (n=1,064). A total of 6507 individuals were screened.
A six-component geriatric assessment of frailty, cognitive function, social support, depressive symptoms, vision, and hearing. Main outcome was major bleeding adjudicated by a physician panel.
At baseline, participants were, on average, 75.5 years old and 49% were women. Mean CHADS-VASc score was 4.5 and the mean HAS-BLED score was 3.3. During 2.0 (± 0.4) years of follow-up, 95 (8.9%) participants developed an episode of major bleeding. After adjusting for key covariates and accounting for competing risk from death, cognitive impairment (hazard ratio [HR] 1.62, 95% confidence interval [CI]: 1.02-2.56) and frailty (HR 2.77, 95% CI 1.38-5.58) were significantly associated with the development of major bleeding.
In older patients with AF taking anticoagulants, cognitive impairment and frailty were independently associated with major bleeding.
在患有心房颤动(AF)的老年患者中,身体、认知和社会心理方面的限制普遍存在。这些情况对大出血的预后价值尚不清楚。
确定老年患者在接受抗凝治疗的 AF 患者中,老年病状况是否与大出血有前瞻性关联。
2016 年至 2020 年,在马萨诸塞州和佐治亚州的心脏病学、电生理学和初级保健诊所进行了为期 2 年的多中心队列研究。
诊断为 AF,年龄 65 岁或以上,CHADS-VASc 评分 2 分或更高,服用口服抗凝剂(n=1064)。共有 6507 人接受了筛查。
采用衰弱、认知功能、社会支持、抑郁症状、视力和听力等六个方面的老年综合评估。主要结局是由医生小组判定的大出血。
基线时,参与者的平均年龄为 75.5 岁,49%为女性。平均 CHADS-VASc 评分为 4.5,平均 HAS-BLED 评分为 3.3。在 2.0(±0.4)年的随访期间,95(8.9%)名参与者发生了大出血事件。在调整了关键协变量并考虑了死亡的竞争风险后,认知障碍(危险比 [HR] 1.62,95%置信区间 [CI]:1.02-2.56)和衰弱(HR 2.77,95% CI 1.38-5.58)与大出血的发生显著相关。
在服用抗凝剂的老年 AF 患者中,认知障碍和衰弱与大出血独立相关。